genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline…
News
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
News
Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms
Natural Products
Civil War Battlefield Natural Therapies Found to be Effective against Modern-Day…
News
Tissue Engineering Improved by Use of Molecular Tethers
Insights
Neuroscience
Human-Derived Brain Models
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline…
News
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
News
Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms
Natural Products
Civil War Battlefield Natural Therapies Found to be Effective against Modern-Day…
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
GlaxoSmithKline
GlaxoSmithKline
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
GlaxoSmithKline
Thermo Fisher to Acquire API Plant in Cork, Ireland from GSK
GlaxoSmithKline
GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B Alliance
GlaxoSmithKline
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
GlaxoSmithKline
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
GlaxoSmithKline
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
GlaxoSmithKline
GSK Sells Psoriasis/Dermatitis Candidate Tapinarof to Dermavant
GlaxoSmithKline
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
GlaxoSmithKline
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
GlaxoSmithKline
From J.P. Morgan: More Capital Will Boost Biopharma M&A in 2018
GlaxoSmithKline
GSK, Plasticell Partner to Produce Hematopoietic Cells from iPSCs
GlaxoSmithKline
Citing Patient Deaths, FDA Panel Faults Safety Data for J&J Arthritis...
GlaxoSmithKline
GSK Launches Up-to-$43M AI-Focused Collaboration with Exscientia
GlaxoSmithKline
Epizyme Receives $10M Milestone Payment from GSK
GlaxoSmithKline
OncoMed Reviews Portfolio after Tarextumab, Brontictuzumab Setbacks
GlaxoSmithKline
Regeneron, GSK, UK Biobank Launch Gene-Sequencing Collaboration
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![C. elegans. [Source: Arturo Agostino]](https://www.genengnews.com/wp-content/uploads/2018/08/169244_web1201231412-218x150.jpg "Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms")
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-265x198.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")